Lv1
48 积分 2024-07-03 加入
177Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors
1天前
待确认
Claudin 18.2 as a novel therapeutic target
2个月前
已完结
Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice
4个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
5个月前
已完结
Pretargeted Trop-2 immunoPET for rapid, selective detection of pancreatic tumors
7个月前
已完结
PILRα on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunity
7个月前
已完结
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
9个月前
已完结
[Recommendations for diagnosis and treatment of psoriatic arthritis in China]
11个月前
已完结
The endosomal-lysosomal system in ADC design and cancer therapy
11个月前
已完结
Endocytosis and signalling: intertwining molecular networks
11个月前
已完结
皖公网安备34019202002308
